FineMark National Bank & Trust’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-723
Closed -$40K 1382
2016
Q1
$40K Sell
723
-19
-3% -$1.08K ﹤0.01% 625
2015
Q4
$46K Hold
742
0.01% 612
2015
Q3
$50K Sell
742
-463
-38% -$35.6K 0.01% 625
2015
Q2
$95K Sell
1,205
-452
-27% -$32.5K 0.01% 497
2015
Q1
$119K Buy
1,657
+3
+0.2% +$192 0.02% 445
2014
Q4
$101K Sell
1,654
-47
-3% -$2.74K 0.01% 484
2014
Q3
$83K Buy
1,701
+240
+16% +$11.7K 0.01% 520
2014
Q2
$66K Buy
1,461
+66
+5% +$2.9K 0.01% 559
2014
Q1
$63K Buy
1,395
+144
+12% +$7.1K 0.01% 555
2013
Q4
$60K Hold
1,251
0.01% 538
2013
Q3
$50K Buy
1,251
+36
+3% +$1.34K 0.01% 573
2013
Q2
$40K Buy
+1,215
New +$39.4K 0.01% 612

Other funds holding ACHC

FineMark National Bank & Trust's ACHC Position: Q2 2016 in Review

FineMark National Bank & Trust sold out of Acadia Healthcare (ACHC) in Q2 2016, closing a stake of 723 shares — an estimated $40K sold.

FineMark National Bank & Trust first reported a position in ACHC in Q2 2013 and held it in 12 quarters. The position peaked at $119K in Q1 2015. 253 funds tracked by Wall St. Rank hold ACHC as of Q2 2016.

  • FineMark National Bank & Trust reported no remaining Acadia Healthcare position as of Q2 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 723 Acadia Healthcare shares in Q2 2016, an estimated $40K.
  • FineMark National Bank & Trust first reported a position in Acadia Healthcare in Q2 2013 and held it in 12 quarters.
  • FineMark National Bank & Trust's Acadia Healthcare position peaked at $119K in Q1 2015.
  • 253 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2016.

Based on FineMark National Bank & Trust's 13F filing for Q2 2016, filed 8 Aug 2016.